MARAL BAKIR: Open Payments
NPI 1184229668 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$305 in 5 payments from 3 companies in 2025. Trend: 2023 $145 · 2024 $910 · 2025 $305
Food & beverage: $305
| Company | Payments | Amount |
|---|---|---|
| SK Life Science, Inc. | 3 | $196 |
| JAZZ PHARMACEUTICALS INC. | 1 | $72 |
| UCB, Inc. | 1 | $36 |
Products named: XCOPRI, EPIDIOLEX, Fintepla.
Industry payments across CA — which companies pay providers there.
